Focusing on developing new drugs for therapies such as cellular therapy and gene therapy, as well as antibody drugs, Genbase is collaborating with clinicians to transform important clinical research findings and develop therapeutic products to meet urgent clinical needs. Genbase has established its own R&D pipeline for nine cellular therapy drugs and eight antibody drugs. It has also signed long-term cooperation agreements with a number of leaders in specific fields.
Learn More
ICP 19028100 -131011502008633 Copyright © 2019 All RIGHTS GENEPOWERED BY VTHINK
Search Here ... |